Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01508221 : Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Plan to undergo single or five fraction radiosurgery for a metastatic brain tumor

- Diagnosis of a metastatic brain tumor may be accomplished by histologic confirmation
or by clinical confirmation by the treating physician based on MR imaging
characteristics in the setting of a known history of cancer

- Age > 18 years

- Partial or total resection of a metastatic tumor are eligible

Exclusion Criteria:

- Known sensitivity to vitamin E or Trental

- Recent intracranial bleed or retinal hemorrhage

- Treatment with a non-approved or investigational drug within 30 days before day 1 of
study treatment

- History of Avastin treatment

- Anticipated need for treatment with Avastin

- History of bleeding disorder

- History of liver disorder
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01508221      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740